Search Results

• • 76 

    Academic Journals

  • Sort by: sorttype.publication.date.desc Newest sorttype.publication.date.asc Oldest sorttype.relevance Relevance

• Experimental PVC material challenge in subjects with occupational PVC exposure

  Authors:Anneli Tuomainen, Harri Stark, Markku Seuri, Maija-Riitta Hirvonen, Markku Linnainmaa, Anne Sieppi, et al.From:Environmental Health Perspectives (Vol. 114, Issue 9) Peer-Reviewed

  Sept. 20064,371 words Article 1310LBACKGROUND: Polyvinyl chloride (PVC) materials have been linked to asthma in several epidemiologic studies, but the possible causal factors remain unknown. PARTICIPANTS: We challenged 10 subjects experimentally to...

• Comparison of levofloxacin and cefotaxime combined with ofloxacin for ICU patients with community-acquired pneumonia who do not require vasopressors *

  Authors:Olivier Leroy, Pierre Saux, Jean-Pierre Bedos, and Evelyne CaulinFrom:Chest (Vol. 128, Issue 1) Peer-Reviewed

  July 20057,728 words Article Study objectives: To evaluate the efficacy and tolerability of levofloxacin (L) as monotherapy in patients with severe community-acquired pneumonia (CAP) in comparison with therapy using a combination of cefotaxime (C)...

• Journal impact factors for 2000: Thorax flying yet higher

  From:Thorax (Vol. 56, Issue 8) Peer-Reviewed

  Aug. 2001423 words Brief article The journal impact factors for 2000 have recently been released and the good news for Thorax is that it has again increased its impact factor from 3.44 in 1999 [1] to 3.98, and it has narrowed the gap considerably on...

• Home diagnosis of sleep apnea: a systematic review of the literature *: an evidence review cosponsored by the American Academy of Sleep Medicine, the American College of Chest Physicians, and the American Thoracic Society

  Authors:W. Ward Flemons, Michael R. Littner, James A. Rowley, Peter Gay, W. McDowell Anderson, David W. Hudgel, et al.From:Chest (Vol. 124, Issue 4) Peer-Reviewed

  Oct. 200325,056 words Article Key words: diagnosis; likelihood ratios polysomnography/methods: research design; review literature; sensitivity and Specificity; sleep apnea syndromes Abbreviations: AASM = American Academy of Sleep Medicine; ACCP =...

• Comparison of British Thoracic Society and American Thoracic Society reintroduction guidelines for anti-tuberculous therapy induced liver injury

  From:Journal of Pakistan Medical Association (Vol. 64, Issue 8)

  Aug. 31, 20142,771 words Clinical report 1420LByline: Bader Faiyaz Zuberi Faisal Faiyaz Zuberi Nimrah Bader Haris Alvi and Javeria Salahuddin AbstractObjective: To compare the efficacy of British Thoracic Society and American Thoracic Society guidelines for re-...

• Pharmacologic Treatments for Idiopathic Pulmonary Fibrosis

  Author:Kelly DunnFrom:Clinician Reviews (Vol. 28, Issue 4) Peer-Reviewed

  Apr. 20182,742 words Article 1570LThis chronic disease has historically lacked an effective treatment option, but the FDA recently approved two: pirfenidone and nintedanib. This discussion of these new drug therapies--including mechanism of action,...

• Pulmonary infections and resistance to antibiotics: recent information

  Authors:Antoni Torres, Michael S. Niederman, Antonio Artigas, and Jean CarletFrom:Expert Review of Anti-infective Therapy (Vol. 10, Issue 10) Peer-Reviewed

  Oct. 20123,006 words Report 1460LAuthor(s): Antoni Torres 1 1 , Michael S Niederman 2 2 , Antonio Artigas 3 3 , Jean Carlet [*] 4 4 Keywords: Keywords: antimicrobial resistance; influenza; methicillin-resistant Staphylococcus aureus ;...

• Defining effective treatment for latent tuberculosis infection: patient selection requires careful weighing of risks

  Authors:Michael C. Boyars and Anita C. MercadoFrom:Journal of Respiratory Diseases (Vol. 25, Issue 11) Peer-Reviewed

  Nov. 20042,664 words Article ABSTRACT: One of the keys to decreasing the incidence of active tuberculosis (TB) is preventing reactivation by aggressively treating latent TB infection. The American Thoracic Society and the CDC endorse 2 regimens...

• CAP: Advice from the new guidelines: The guidelines for managing this ubiquitous and sometimes insidious disease have been updated. Here is a review of the main points. (Cover Story)

  Author:Dorothy L. PennachioFrom:Patient Care (Vol. 35, Issue 23) Peer-Reviewed

  Dec. 15, 20013,223 words Article In 2000 and 2001 the Infectious Disease Society of America (IDSA) and the American Thoracic Society (ATS) updated their guidelines for the management of community-acquired pneumonia (CAP). (1,2) The societies'...

• Multicenter cross-sectional study of nontuberculous mycobacterial infections among cystic fibrosis patients, Israel

  Authors:Isaac Levy, Galia Grisaru-Soen, Liat Lerner-Geva, Eitan Kerem, Hana Blau, Lea Bentur, et al.From:Emerging Infectious Diseases (Vol. 14, Issue 3) Peer-Reviewed

  Mar. 20084,422 words Article 1450LThis 2-year cross-sectional evaluation of nontuberculous mycobacterial (NTM) infections involved all Israeli medical centers that treat cystic fibrosis patients. The study comprised 186 patients whose sputum was...

• Post-test: expiration date: December 31, 2016

  From:Clinical Advisor (Vol. 19, Issue 6)

  June 2016402 words Article 2730LCredit Designation: Albert Einstein College of Medicine designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit(s)[TM]. Physicians should claim only the credit commensurate with the extent...

• At least three FE[V.sub.1] blows are required at each time point during the assessment of bronchial hyperresponsiveness

  Authors:Ashwini Jantikar, Sandeep Sewlikar, Bill Brashier, Manisha Maganji, Sundeep Salvi, Donald W. Cockcroft, et al.From:Chest (Vol. 128, Issue 1) Peer-Reviewed

  July 20051,345 words Article To the Editor: Bronchoprovocation tests are used routinely in clinical practice and research to detect and quantify the presence of bronchial hyperresponsiveness. Histamine, methacholine, and 5'-adenosine...

• Tuberculosis treatment recommendations revised following reports of liver injury. (Citations)

  From:The Journal of Critical Illness (Vol. 16, Issue 11) Peer-Reviewed

  Nov. 2001386 words Brief article Centers for Disease Control and Prevention, Atlanta. Update: fatal and severe liver injuries associated with rifampin and pyrazinamide for latent tuberculosis infection, and revisions in American Thoracic Society/CDC...

• Laboratory aspects of clinically significant rapidly growing mycobacteria

  Authors:R. Set and J. ShastriFrom:Indian Journal of Medical Microbiology (Vol. 29, Issue 4)

  October-December 20118,018 words Article 1610LByline: R. Set, J. Shastri The pathogenic potential of the rapidly growing mycobacteria (RGM) has started being recognized. This is due to more sensitive and specific techniques in the laboratory. The RGM are...

• Using CT scans in the assessment of COPD: what role can CT scanning now play in the evaluation of chronic obstructive pulmonary disease (COPD)?

  Author:Edwin J.R. Van BeekFrom:Journal of Respiratory Diseases (Vol. 29, Issue 9) Peer-Reviewed

  Sept. 2008658 words Article 1540LThis question deserves a broad answer, considering how much has changed since the old high-resolution CT (HRCT) scans with 1-mm slices and 1-cm intervals. (1-3) The advent of multidetector row CT has had a significant...

• Community-acquired pneumonia advice updated

  Author:Barbara J. RutledgeFrom:Family Practice News (Vol. 37, Issue 8)

  Apr. 15, 2007621 words Article 1440LNew consensus guidelines could help primary care and emergency medicine physicians better manage community-acquired pneumonia in immunocompetent adults. A joint committee of the Infectious Diseases Society of America...

• Conference report: simplifying asthma treatment regimens aids patient adherence: simplicity is the key to asthma control and compliance. Data presented at the recent annual conference of the American Thoracic Society in Seattle suggests that patient compliance could be improved by taking simple steps to raise patient expectations

  Author:Jenny BryanFrom:Practice Nurse (Vol. 26, Issue 9)

  Nov. 28, 20031,924 words Article Asking asthma patients how well they are sleeping, checking whether they are able to take part in the everyday activities that are important to them, providing them with self-management plans and simplifying their...

• Validity of the American Thoracic Society and other spirometric algorithms using FVC and forced expiratory volume at 6 s for predicting a reduced total lung capacity *

  Authors:Maureen P. Swanney, Lutz E. Beckert, Chris M. Frampton, Lauren A. Wallace, Robert L. Jensen, and Robert O. CrapoFrom:Chest (Vol. 126, Issue 6) Peer-Reviewed

  Dec. 20042,920 words Article Objectives: (1) To compare the performance of three spirometric algorithms developed to predict whether the total lung capacity (TLC) is reduced vs normal or increased, (2) to determine if forced expiratory volume at 6...

• Pulmonary Mycobacterium kansasii disease in immunocompetent host: Treatment outcomes with short-course chemotherapy

  Authors:C. Padmapriyadarsini, D. Nair, N. Gomathi, and B. VelayudhamFrom:Indian Journal of Medical Microbiology (Vol. 34, Issue 4)

  October-December 20161,516 words Article 1650LByline: C. Padmapriyadarsini, D. Nair, N. Gomathi, B. Velayudham Mycobacterium kansasii, most virulent of all atypical mycobacteria, causes pulmonary disease identical to the disease caused by Mycobacterium...

• Identifying pathogens in community-acquired pneumonia

  From:Clinician Reviews (Vol. 15, Issue 6) Peer-Reviewed

  June 2005364 words Brief article Metersky ML. When to obtain cultures from patients with community-acquired pneumonia. J Respir Dis. 2005;26:143-148. When managing a patient with community-acquired pneumonia (CAP), how can clinicians balance...